Funder: Novo Nordisk
Due Dates (Anticipated): September 2026
Funding Amounts: Up to DKK 5 million (standard projects) or DKK 10 million (collaborative projects) per grant; up to 3 years; total call budget DKK 100 million.
Summary: Supports translational research in regenerative medicine, advancing solutions to key challenges and promoting collaboration in the Nordic region and beyond.